Symbols

FTXH

First Trust Nasdaq Pharmaceuticals ETF·NASDAQ

--(--)

Key Stats

Assets Under Management

21.81MUSD

Fund Flows (1Y)

2.93MUSD

Dividend Yield

1.38%

Discount/Premium to NAV

0.09%

Shares Outstanding

650.00K

Expense Ratio

0.60%

About First Trust Nasdaq Pharmaceuticals ETF

Issuer

First Trust Advisors L.P.

Brand

First Trust

Home Page

http://www.ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FTXH

Inception Date

Sep 20, 2016

Structure

Open-Ended Fund

Index Tracked

Nasdaq US Smart Pharmaceuticals Index

Management Style

Passive

Dividend Treatment

Distributes

Distribution Tax Treatment

Qualified dividends

Income Tax Type

Capital Gains

Max ST Capital Gains Rate

39.60%

Max LT Capital Gains Rate

20.00%

Primary Advisor

First Trust Advisors LP

Distributor

First Trust Portfolios LP

FTXH holds a concentrated basket of 30 highly liquid pharmaceutical stocks weighted according to various factors. While many funds perform a basic liquidity screen as part of their index construction and rebalancing, FTXH goes beyond the basic screen and uses liquidity for selection. The 30 most liquid pharmaceutical stocks in the US are chosen for inclusion in the index as determined by 3-month average daily traded volume. The selected constituents are then ranked and weighted on three different factors: 1) strong growth, as exhibited by 3-, 6-, 9-, and 12-month average price returns, 2) attractive value, evaluated by cash-flow-to-price, and 3) low volatility, based on historical price fluctuations. Single security weights are capped at 8%. The index is rebalanced quarterly and reconstituted annually.